Value of Urinary Neutrophil Gelatinase-Associated Lipocalin versus Conventional Biomarkers in Predicting Response to Treatment of Active Lupus Nephritis
Introduction. Lupus nephritis (LN) affects almost two-thirds of systemic lupus erythematosus (SLE) patients. Despite initial aggressive therapy, up to 25% of patients with LN will progress to permanent renal damage. Conventional serum markers for LN lack the sensitivity of an ideal biomarker. Urinar...
Saved in:
| Main Authors: | Mohamed Abd El-Mohsen, Ahmed Tawfik, Walid Bichari, Sahar Shawky, Gamal Mady, Mohamed Hassan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | International Journal of Nephrology |
| Online Access: | http://dx.doi.org/10.1155/2020/8855614 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutrophil gelatinase-associated lipocalin (NGAL) in lupus nephritis and beyond
by: Elisabet Svenungsson, et al.
Published: (2025-01-01) -
Effect of continuous nursing on neutrophil gelatinase-associated lipocalin in patients with lupus nephritis
by: ZHANG Xian-qin, et al.
Published: (2018-01-01) -
Neutrophil gelatinase-associated lipocalin is a urine-based biomarker for diagnosing active lupus nephritis
by: Anthony Chakma, et al.
Published: (2025-04-01) -
Urinary Neutrophil Gelatinase-Associated Lipocalin Levels in Neonates
by: Chi-Nien Chen, et al.
Published: (2016-06-01) -
Is It Prime Time for Neutrophil Gelatinase-Associated Lipocalin?
by: Lui G. Forni, et al.
Published: (2024-08-01)